• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sirt3 通过减少 Mdm2 介导的 p53 降解来抑制肝癌细胞生长。

Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation.

机构信息

Department of Pharmacology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, PR China.

出版信息

Biochem Biophys Res Commun. 2012 Jun 22;423(1):26-31. doi: 10.1016/j.bbrc.2012.05.053. Epub 2012 May 17.

DOI:10.1016/j.bbrc.2012.05.053
PMID:22609775
Abstract

Sirt3 is a member of the mammalian sirtuin family that is localized to mitochondria and plays a role in the control of the metabolic activity. Recently, Sirt3 has been reported to be associated with the deregulating metabolism of cancer cells. However, the role of Sirt3 in hepatocellular carcinoma (HCC) has never been studied. In this study, we found that Sirt3 protein expression was downregulated in human HCC tissue. We also showed that overexpression of Sirt3 using adenovirus inhibited HCC cell growth (two cell lines: HepG2 and HuH-7 cells) and induced apoptosis, which was evidenced by the increase of LDH leakage, enhancement of TUNEL-positive cells number and promotion of AIF translocation to nuclei. Sirt3 overexpression reduced the intracellular NAD(+) level, repressed the ERK1/2 signaling pathway, and activated the Akt and JNK signaling pathways. Furthermore, Sirt3 overexpression upregulated p53 protein level through downregulating Mdm2 and thereby slowing p53 degradation. Collectively, our data suggests that Sirt3 may play an important role in HCC development and progression and may be a promising therapeutic target for HCC.

摘要

Sirt3 是哺乳动物沉默调节蛋白家族的一员,定位于线粒体,在代谢活性的控制中发挥作用。最近,Sirt3 被报道与癌细胞代谢的失调有关。然而,Sirt3 在肝细胞癌 (HCC) 中的作用从未被研究过。在这项研究中,我们发现 Sirt3 蛋白表达在人 HCC 组织中下调。我们还表明,使用腺病毒过表达 Sirt3 抑制 HCC 细胞生长(两种细胞系:HepG2 和 HuH-7 细胞)并诱导细胞凋亡,这表现在 LDH 漏出增加、TUNEL 阳性细胞数量增加以及 AIF 向细胞核易位增加。Sirt3 过表达降低细胞内 NAD+水平,抑制 ERK1/2 信号通路,激活 Akt 和 JNK 信号通路。此外,Sirt3 过表达通过下调 Mdm2 而上调 p53 蛋白水平,从而减缓 p53 的降解。总之,我们的数据表明,Sirt3 可能在 HCC 的发展和进展中发挥重要作用,可能是 HCC 的一个有前途的治疗靶点。

相似文献

1
Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation.Sirt3 通过减少 Mdm2 介导的 p53 降解来抑制肝癌细胞生长。
Biochem Biophys Res Commun. 2012 Jun 22;423(1):26-31. doi: 10.1016/j.bbrc.2012.05.053. Epub 2012 May 17.
2
Sirt3 is a tumor suppressor in lung adenocarcinoma cells.Sirt3 是肺腺癌细胞中的肿瘤抑制因子。
Oncol Rep. 2013 Sep;30(3):1323-8. doi: 10.3892/or.2013.2604. Epub 2013 Jul 8.
3
{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3).{2-[1-(3-甲氧基羰基甲基-1H-吲哚-2-基)-1-甲基-乙基]-1H-吲哚-3-基}-乙酸甲酯(MIAM)通过上调沉默调节蛋白3(SIRT3)抑制人肝癌生长。
Biomed Pharmacother. 2015 Feb;69:125-32. doi: 10.1016/j.biopha.2014.11.005. Epub 2014 Nov 18.
4
Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.沉默调节蛋白3通过糖原合酶激酶-3β/BCL2相关X蛋白依赖性凋亡途径抑制肝细胞癌生长。
Oncogene. 2016 Feb 4;35(5):631-41. doi: 10.1038/onc.2015.121. Epub 2015 Apr 27.
5
Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway.沉默调节蛋白3通过谷胱甘肽S-转移酶π1/应激活化蛋白激酶信号通路增强人肝癌细胞的药物敏感性。
Oncotarget. 2016 Aug 2;7(31):50117-50130. doi: 10.18632/oncotarget.10319.
6
Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells.通过 CDK4/6 调节 SIRT3 表达增强索拉非尼对肝癌细胞的抗癌作用。
BMC Cancer. 2020 Apr 19;20(1):332. doi: 10.1186/s12885-020-06822-4.
7
SIRT3 functions as a tumor suppressor in hepatocellular carcinoma.SIRT3在肝细胞癌中发挥肿瘤抑制作用。
Tumour Biol. 2017 Mar;39(3):1010428317691178. doi: 10.1177/1010428317691178.
8
Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal‑regulated kinase signaling pathway.Sirt6 通过抑制细胞外信号调节激酶信号通路抑制肝细胞癌细胞生长。
Mol Med Rep. 2014 Mar;9(3):882-8. doi: 10.3892/mmr.2013.1879. Epub 2013 Dec 24.
9
Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.HURP 敲低通过下调 gankyrin 和 p53 积累抑制肝细胞癌细胞的增殖。
Biochem Pharmacol. 2012 Mar 15;83(6):758-68. doi: 10.1016/j.bcp.2011.12.034. Epub 2011 Dec 31.
10
[Role of SIRT3 in regulating proliferation of hepatocellular carcinoma cells in vitro].[沉默信息调节因子3在体外调控肝癌细胞增殖中的作用]
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Feb;36(2):195-9.

引用本文的文献

1
Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma.沉默调节蛋白与肠道微生物群:健康中的动态变化以及从代谢功能障碍到肝细胞癌的历程
Cells. 2025 Mar 20;14(6):466. doi: 10.3390/cells14060466.
2
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions.近期关于突变型 p53 的研究进展:揭示新的致癌作用、降解途径和治疗干预措施。
Biomolecules. 2024 May 31;14(6):649. doi: 10.3390/biom14060649.
3
The association between methylmalonic acid, a biomarker of mitochondrial dysfunction, and risk of prostate cancer.
血液中甲基丙二酸(一种线粒体功能障碍的生物标志物)与前列腺癌风险之间的关联。
Int Urol Nephrol. 2024 Jun;56(6):1879-1885. doi: 10.1007/s11255-024-03944-7. Epub 2024 Jan 27.
4
Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.p53抑制在肝细胞癌发病机制中的作用。
World J Gastrointest Pathophysiol. 2023 Jun 1;14(3):46-70. doi: 10.4291/wjgp.v14.i3.46.
5
The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis.NAD+、SIRTs 相互作用在刺激和拮抗致癌作用中的角色。
Int J Mol Sci. 2023 Apr 27;24(9):7925. doi: 10.3390/ijms24097925.
6
SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth.SIRT3 依赖性去酰化 cyclin E2 可预防肝细胞癌生长。
EMBO Rep. 2023 May 4;24(5):e56052. doi: 10.15252/embr.202256052. Epub 2023 Mar 10.
7
Insights into Regulators of p53 Acetylation.p53 乙酰化调控因子研究进展
Cells. 2022 Nov 29;11(23):3825. doi: 10.3390/cells11233825.
8
The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.组蛋白去乙酰化酶在肝细胞癌中的预后及临床病理意义:一项荟萃分析。
Clin Exp Med. 2023 Sep;23(5):1515-1536. doi: 10.1007/s10238-022-00934-w. Epub 2022 Nov 7.
9
Mitochondrial sirtuin 3 and various cell death modalities.线粒体沉默调节蛋白3与多种细胞死亡方式
Front Cell Dev Biol. 2022 Jul 22;10:947357. doi: 10.3389/fcell.2022.947357. eCollection 2022.
10
SIRT3 inhibitor 3-TYP exacerbates thioacetamide-induced hepatic injury in mice.SIRT3抑制剂3-TYP加剧硫代乙酰胺诱导的小鼠肝损伤。
Front Physiol. 2022 Jul 18;13:915193. doi: 10.3389/fphys.2022.915193. eCollection 2022.